Herpesvirus saimiri-based gene delivery vectors

Current Gene Therapy

Volumn 6, Issue 1, 2006, Pages 1-15

  Griffiths, Rhoswyn A ^a   Boyne, James R ^a   Whitehouse, Adrian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Alpha herpes virus vectors; EBV based vectors; Latency associated nuclear antigen (LANA); Transgene; Tumour xenografts

Indexed keywords

5 [2 BROMOVINYL] 2' DEOXYURIDINE; ANTINEOPLASTIC AGENT; BETA GALACTOSIDASE; CELL NUCLEUS ANTIGEN; GANCICLOVIR; GROWTH HORMONE; HERPESVIRUS VECTOR; HYGROMYCIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; NEOMYCIN; RIBONUCLEOTIDE REDUCTASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIINFLAMMATORY ACTIVITY; ARTIFICIAL CHROMOSOME; BACTERIAL ARTIFICIAL CHROMOSOME; CELL DIVISION; CELL LINE; CELL POPULATION; CELL TRANSFER; CYTOMEGALOVIRUS; DNA SYNTHESIS INHIBITION; DRUG BINDING SITE; ENZYME INHIBITION; EPISOME; GENE TRANSFER; GENETIC DISORDER; GENETIC ENGINEERING; HERPES SIMPLEX VIRUS 1; HERPES VIRUS SAIMIRI; HETEROLOGOUS EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROGENY; PROTEIN SYNTHESIS INHIBITION; REVIEW; RHEUMATOID ARTHRITIS; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; ANIMAL; FIBROBLAST; GENE VECTOR; GENETIC TRANSFORMATION; GENETICS; PHYSIOLOGY; RAT; TRANSGENE; TRANSPORT VESICLE;

BACTERIA (MICROORGANISMS); CYTOMEGALOVIRUS; DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; SAIMIRIINE HERPESVIRUS 2;

ANIMALS; FIBROBLASTS; GENETIC VECTORS; HERPESVIRUS 2, SAIMIRIINE; HUMANS; RATS; TRANSFORMATION, GENETIC; TRANSGENES; TRANSPORT VESICLES;

EID: 33645735204     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652306775515529     Document Type: Review

References (134)

1. Adler, H., Messerle, M., Wagner, M. & Koszinowski, U. H. (2000) Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J. Virol. 74: 6964-74.
2. Advani, S. J., Weichselbaum, R. R., Whitley, R. J. & Roizman, B. (2002) Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin. MicroBiol. Infect. 8: 551-63.
3. Aiyar, A., Tyree, C. & Sugden, B. (1998) The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J. 17: 6394-6403.
4. Albrecht, J., Nicholas, J., Biller, D., Cameron, K., Biesinger, B., Newman, C., Wittmann, S., Craxton, M., Coleman, H. & Fleckenstein, B. (1992a) Primary structure of the herpesvirus saimiri genome. J. Virol. 66: 5047-5058.
5. Albrecht, J. C., Nicholas, J., Cameron, K. R., Newman, C., Fleckenstein, B. & Honess, R. W. (1992b) Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 190: 527-30.
6. Ballestas, M. E., Chatis, P. A. & Kaye, K. M. (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284: 641-644.
7. Ballestas, M. E. & Kaye, K. M. (2001) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J. Virol. 75: 3250-3258.
8. Banerjee, S., Livanos, E. & Vos, J. M. (1995) Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus. Nat. Med. 1: 1303-8.
9. Biesinger, B., Muller-Fleckenstein, I., Simmer, B., Lang, G., Wittmann, S., Platzer, E., Desrosiers, R. C. & Fleckenstein, B. (1992) Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 89: 3116-9.
10. Biesinger, B., Trimble, J. J., Desrosiers, R. C. & Fleckenstein, B. (1990) The divergence between two oncogenic herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology 176: 505-14.
11. Biesinger, B., Tsygankov, A. Y., Fickenscher, H., Emmrich, F., Fleckenstein, B., Bolen, J. B. & Broker, B. M. (1995) The product of the herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p561ck in transformed cells. J. Biol. Chem. 270: 4729-34.
12. Borst, E. M., Crnkovic-Mertens, I. & Messerle, M. (2004) Cloning of beta-herpesvirus genomes as bacterial artificial chromosomes. Methods Mol. Biol. 256: 221-39.
13. Borst, E. M., Hahn, G., Koszinowski, U. H. & Messerle, M. (1999) Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73: 8320-9.
14. Borst, E. M. & Messerle, M. (2003) Construction of a cytomegalovirus-based amplicon: a vector with a unique transfer capacity. Hum. Gene Ther. 14: 959-70.
15. Bublot, M., Lomonte, P., Lequarre, A. S., Albrecht, J. C., Nicholas, J., Fleckenstein, B., Pastoret, P. P. & Thiry, E. (1992) Genetic relationships between bovine herpesvirus 4 and the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri. Virology 190: 654-65.
16. Burton, E. A., Fink, D. J. & Glorioso, J. C. (2002) Gene delivery using herpes simplex virus vectors. DNA Cell Biol. 21: 915-36.
17. Calderwood, M. A., Hall, K. T., Matthews, D. A. & Whitehouse, A. (2004) The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. J. Gen. Virol. 85: 147-153.
18. Calderwood, M. A., White, R. E., Griffiths, R. A. & Whitehouse, A. (2005) Open reading frame 73 is required for Herpesvirus saimiri All-S4 episomal persistence. J. Gen. Virol. 86: 2703-2708.
19. Collins, C. M., Medveczky, M. M., Lund, T. & Medveczky, P. G. (2002) The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome. J. Gen. Virol. 83: 2269-2278.
20. Collins, C. M. & Medveczky, P. G. (2002) Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes. Adv. Cancer Res. 84: 155-74.
21. Conese, M., Auriche, C. & Ascenzioni, F. (2004) Gene therapy progress and prospects: episomally maintained self-replicating systems. Gene Ther. 11: 1735-41.
22. Cotter, M. A., 2nd & Robertson, E. S. (1999) The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264: 254-64.
23. Delecluse, H. J., Hilsendegen, T., Pich, D., Zeidler, R. & Hammerschmidt, W. (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. USA 95: 8245-50.
24. Delecluse, H. J., Kost, M., Feederle, R., Wilson, L. & Hammerschmidt, W. (2001) Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus. J. Virol. 75: 2921-8.
25. Delecluse, H. J., Pich, D., Hilsendegen, T., Baum, C. & Hammerschmidt, W. (1999) A first-generation packaging cell line for Epstein-Barr virus-derived vectors. Proc. Natl. Acad. Sci. USA 96: 5188-93.
26. Desrosiers, R. C., Daniel, P. S., Waldron, L. M. & Letvin, N. L. (1986) Nononcogenic deletion mutants of herpesvirus saimiri are defective for in. vitro immortalization. J. Virol. 57: 701-705.
27. Desrosiers, R. C., Kamine, J., Bakker, A., Silva, D., Woychik, R. P., Sakai, D. D. & Rottman, F. M. (1985) Synthesis of bovine growth hormone in primates by using a herpesvirus vector. Mol. Cell Biol. 5: 2796-803.
28. Dittmer, D., Lagunoff, M., Renne, R., Staskus, K., Haase, A. & Ganem, D. (1998) A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 72: 8309-8315.
29. Doody, G. M., Leek, J. P., Bali, A. K., Ensser, A., Markham, A. F. & de Wynter, E. A. (2005) Marker gene transfer into human haemopoietic cells using a herpesvirus saimiri-based vector. Gene Ther. 12: 373-9.
30. Duboise, S. M., Guo, J., Czajak, S., Lee, H., Veazey, R., Desrosiers, R. C. & Jung, J. U. (1998a) A role for herpesvirus saimiri orf14 in transformation and persistent infection. J. Virol. 72: 6770-6.
31. Duboise, S. M., Guo, J., Czajak, S., Desrosiers, R. C. & Jung, J. U. (1998b) STP and Tip are essential for herpesvirus saimiri oncogenicity. J. Virol. 72: 1308-13.
32. Edinger, M., Cao, Y. A., Hornig, Y. S., Jenkins, D. E., Verneris, M. R., Bachmann, M. H., Negrin, R. S. & Contag, C. H. (2002) Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur. J. Cancer 38: 2128-36.
33. Ensser, A., Pfinder, A., Muller-Fleckenstein, I. & Fleckenstein, B. (1999) The URNA genes of herpesvirus saimiri (strain C488) are dispensable for transformation of human T cells in vitro. J. Virol. 73: 10551-5.
34. Fickenscher, H., Biesinger, B., Knappe, A., Wittmann, S. & Fleckenstein, B. (1996) Regulation of the herpesvirus saimiri oncogene stpC, similar to that of T-cell activation genes, in growth-transformed human T lymphocytes. J. Virol. 70: 6012-9.
35. Fickenscher, H., Bokel, C., Knappe, A., Biesinger, B., Meinl, E., Fleischer, B., Fleckenstein, B. & Broker, B. M. (1997) Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus saimiri. J. Virol. 71: 2252-63.
36. Fickenscher, H. & Fleckenstein, B. (2001) Herpesvirus saimiri. Philosophical Transactions of the Royal Society 356: 545-567.
37. Fink, D. J. & Glorioso, J. C. (1997a) Engineering herpes simplex virus vectors for gene transfer to neurons. Nat. Med. 3: 357-9.
38. Fink, D. J. & Glorioso, J. C. (1997b) Herpes simplex virus-based vectors: problems and some solutions. Adv. Neurol. 72: 149-56.
39. Friedman, S. L. (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275: 2247-50.
40. Frolova-Jones, E. A., Ensser, A., Stevenson, A. J., Kinsey, S. E. & Meredith, D. M. (2000) Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors. J. HematoTher. Stem Cell Res. 9: 573-81.
41. Gahn, T. A. & Schildkraut, C. L. (1989) The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58: 527-35.
42. Gao, R., McCormick, C. J., Arthur, M. J., Ruddell, R., Oakley, F., Smart, D. E., Murphy, F. R., Harris, M. P. & Mann, D. A. (2002) High efficiency gene transfer into cultured primary rat and human hepatic stellate cells using baculovirus vectors. Liver 22: 15-22.
43. Geller, A. I. & Breakefield, X. O. (1988) A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science 241: 1667-9.
44. Giles, M. S., Smith, P. G., Coletta, P. L., Hall, K. T. & Whitehouse, A. (2003) The herpesvirus saimiri ORF 73 regulatory region provides long-term transgene expression in human carcinoma cell lines. Cancer Gene Ther. 10: 49-56.
45. Glorioso, J. C. & Fink, D. J. (2004) Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu. Rev. MicroBiol, 58: 253-71.
46. Grassmann, R. & Fleckenstein, B. (1989) Selectable recombinant herpesvirus saimiri is capable of persisting in a human T-cell line. J. Virol. 63: 1818-1821.
47. Hall, K. T., Giles, M. S., Goodwin, D. J., Calderwood, M. A., Carr, I. M., Stevenson, A. J., Markham, A. F. & Whitehouse, A. (2000) Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri. J. Virol. 74: 7331-7337.
48. Hiller, C., Tamguney, G., Stolte, N., Matz-Rensing, K., Lorenzen, D., Hor, S., Thurau, M., Wittmann, S., Slavin, S. & Fickenscher, H. (2000a) Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus. Virology 278: 445-55.
49. Hiller, C., Wittmann, S., Slavin, S. & Fickenscher, H. (2000b) Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector. Gene Ther. 7: 664-74.
50. Hoggarth, J. H., Jones, E., Ensser, A. & Meredith, D. M. (2004) Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector. Cancer Gene Ther. 11: 613-24.
51. Horsburgh, B. C., Hubinette, M. M., Qiang, D., MacDonald, M. L. & Tufaro, F. (1999) Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther. 6: 922-30.
52. Hu, J., Garber, A. C. & Renne, R. (2002) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76: 11677-11687.
53. Huertas, D., Howe, S., McGuigan, A. & Huxley, C. (2000) Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells. Hum. Mol. Genet 9: 617-29.
54. Inoue, R., Moghaddam, K. A., Ranasinghe, M., Saeki, Y., Chiocca, E. A. & Wade-Martins, R. (2004) Infectious delivery of the 132 kb CDKN2A /CDKN2B genomic DNA region results in correctly spliced gene expression and growth suppression in glioma cells. Gene Ther. 11: 1195-204.
55. Ito, S., Gotoh, E., Ozawa, S. & Yanagi, K. (2002) Epstein-Barr virus nuclear antigen-1 is highly colocalized with interphase chromatin and its newly replicated regions in particular. J. Gen. Virol. 83: 2377-2383.
56. Ito, S. & Yanagi, K. (2003) Epstein-Barr virus (EBV) nuclear antigen 1 colocalizes with cellular replication foci in the absence of EBV plasmids. J. Virol, 77: 3824-3831.
57. Janoschek, N., van de Leur, E., Gressner, A. M. & Weiskirchen, R. (2004) Induction of cell death in activated hepatic stellate cells by targeted gene expression of the thymidine kinase/ganciclovir system. BioChem. Biophys. Res. Commun. 316: 1107-15.
58. Jung, J. U. & Desrosiers, R. C. (1991) Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488. J. Virol. 65: 6953-60.
59. Jung, J. U. & Desrosiers, R. C. (1995) Association of the viral oncoprotein STP-C488 with cellular ras. Mol. Cell Biol. 15: 6506-12.
60. Jung, J. U., Lang, S. M., Jun, T., Roberts, T. M., Veillette, A. & Desrosiers, R. C. (1995) Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri. J. Virol. 69: 7814-22.
61. Jung, J. U., Trimble, J. J., King, N. W., Biesinger, B., Fleckenstein, B. W. & Desrosiers, R. C. (1991) Identification of transforming genes of subgroup A and C strains of herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 88: 7051-5.
62. Kanda, T., Otter, M. & Wahl, G. M. (2001) Coupling of mitotic chromosome tethering and replication competence in Epstein-Barr virus-based plasmids. Mol. Cell Biol. 21: 3576-3588.
63. Kapoor, P. & Frappier, L. (2003) EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes. J. Virol. 77: 6946-6956.
64. Kapoor, P., Shire, K. & Frappier, L. (2001) Reconstitution of Epstein-Barr virus-based plasmid partitioning in budding yeast. EMBO J 20: 222-230.
65. Kaschka-Dierich, C., Bauer, I., Fleckenstein, B. & Desrosiers, R. C. (1981) Episomal and nonepisomal herpesvirus DNA in lymphoid tumor cell lines. Hamatol. Bluttransfus. 26: 197-203.
66. Kedes, D., H., Lagunoff, M., Renne, R. & Ganem, D. (1997) Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Invest. 100: 2606-2610.
67. Kelleher, Z. T., Fu, H., Livanos, E., Wendelburg, B., Gulino, S. & Vos, J. M. (1998) Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells. Nat. Biotechnol. 16: 762-8.
68. Knappe, A., Feldmann, G., Dittmer, U., Meinl, E., Nisslein, T., Wittmann, S., Matz-Rensing, K., Kirchner, T., Bodemer, W. & Fickenscher, H. (2000) Herpesvirus saimiri-transformed macaque T cells are tolerated and do not cause lymphoma after autologous reinfusion. Blood 95: 3256-61.
69. Koons, M. D., Van Scoy, S. & Hearing, J. (2001) The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements. J. Virol. 75: 10582-92.
70. Krithivas, A., Fujimuro, M., Weidner, M., Young, D. B. & Hayward, S. D. (2002) Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76: 11596-11604.
71. Lalioti, M. & Heath, J. (2001) A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli. Nucleic. Acids Res. 29: E14.
72. Latchman, D. S. (2002) Herpes simplex virus vectors for gene delivery to a variety of different cell types. Curr. Gene Ther. 2: 415-26.
73. Lee, M.-A., Diamond, M. E. & Yates, J. L. (1999) Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J. Virol. 73: 2974-2982.
74. Leight, E. R. & Sugden, B. (2000) EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10: 83-100.
75. Li, Q., Harju, S. & Peterson, K. R. (1999) Locus control regions: coming of age at a decade plus. Trends Genet. 15: 403-8.
76. Lund, T., Medveczky, M. M., Geck, P. & Medveczky, P. G. (1995) A herpesvirus saimiri protein required for interleukin-2 independence is associated with membranes of transformed T cells. J. Virol. 69: 4495-9.
77. Lupton, S. & Levine, A. J. (1985) Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol. Cell. Biol. 5: 2533-42.
78. Mahmood, K., Prichard, M. N., Duke, G. M., Kemble, G. W. & Spaete, R. R. (2005) Human cytomegalovirus plasmid-based amplicon vector system for gene therapy. Genet. Vaccines Ther. 3: 1-11.
79. Marechal, V., Dehee, A., Chikhi-Brachet, R., Piolot, T., Coppey-Moisan, M. & Nicolas, J.-C. (1999) Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol. 73: 4385-4392.
80. Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F. & Martuza, R. L. (2000) Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 7: 867-74.
81. Markovitz, N. S. & Roizman, B. (2000) Replication-competent herpes simplex viral vectors for cancer therapy. Adv. Virus. Res. 55: 409-24.
82. McMenamin, M. M., Byrnes, A. P., Charlton, H. M., Coffin, R. S., Latchman, D. S. & Wood, M. J. (1998a) A gamma34.5 mutant of herpes simplex 1 causes severe inflammation in the brain. Neuroscience 83: 1225-37.
83. McMenamin, M. M., Byrnes, A. P., Pike, F. G., Charlton, H. M., Coffin, R. S., Latchman, D. S. & Wood, M. J. (1998b) Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS. Gene Ther. 5: 594-604.
84. Messerle, M., Crnkovic, I., Hammerschmidt, W., Ziegler, H. & Koszinowski, U. H. (1997) Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. USA 94: 14759-63.
85. Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D. & Martuza, R. L. (1995) Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med. 1: 938-43.
86. Neipel, F., Albrecht, J. & Fleckenstein, B. (1997) Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovinis human herpesvirus 8: determinants of its pathogenicity? J. Virol. 71: 4187-4192.
87. Olschowka, J. A., Bowers, W. J., Hurley, S. D., Mastrangelo, M. A. & Federoff, H. J. (2003) Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol. Ther. 7: 218-27.
88. Piolot, T., Tramier, M., Coppey, M., Nicolas, J.-C. & Marechal, V. (2001) Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J. Virol. 75: 3948-3959.
89. Post, D. E., Fulci, G., Chiocca, E. A. & Van Meir, E. G. (2004) Replicative oncolytic herpes simplex viruses in combination cancer therapies. Curr. Gene Ther. 4: 41-51.
90. Prieto, J., Herraiz, M., Sangro, B., Qian, C., Mazzolini, G., Melero, I. & Ruiz, J. (2003) The promise of gene therapy in gastrointestinal and liver diseases. Gut 52: Suppl 2, ii49-54.
91. Rawlins, D. R., Milman, G., Hayward, S. D. & Hayward, G. S. (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA- 1) to clustered sites in the plasmid maintenance region. Cell 42: 859-68.
92. Roizman, B., Carmichael, L. E., Deinhardt, F., de-The, G., Nahmias, A. J., Plowright, W., Rapp, F., Sheldrick, P., Takahashi, M. & Wolf, K. (1981) Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses. InterVirol. 16: 201-17.
93. Rother, R. P., Rollins, S. A., Fodor, W. L., Albrecht, J. C., Setter, E., Fleckenstein, B. & Squinto, S. P. (1994) Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J. Virol. 68: 730-7.
94. Rowntree, R. K., Vassaux, G., McDowell, T. L., Howe, S., McGuigan, A., Phylactides, M., Huxley, C. & Harris, A. (2001) An element in intron 1 of the CFTR gene augments intestinal expression in. vivo. Hum. Mol. Genet. 10: 1455-64.
95. Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y. & Moore, P. S. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) Proc. Natl. Acad. Sci. USA 93: 14862-14867.
96. Saeki, Y., Fraefel, C., Ichikawa, T., Breakefield, X. O. & Chiocca, E. A. (2001) Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther. 3: 591-601.
97. Saeki, Y., Ichikawa, T., Saeki, A., Chiocca, E. A., Tobler, K., Ackermann, M., Breakefield, X. O. & Fraefel, C. (1998) Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther. 9: 2787-94.
98. Samaniego, L. A., Neiderhiser, L. & DeLuca, N. A. (1998) Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72: 3307-20.
99. Sarid, R., Flore, O., Bohenzky, R. A., Chang, Y. & Moore, P. S. (1998) Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1) J. Virol. 72: 1005-1012.
100. Sears, J., Kolman, J., Wahl, G. M. & Aiyar, A. (2003) Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1. J. Virol. 77: 11767-11780.
101. Sena-Esteves, M., Saeki, Y., Fraefel, C. & Breakefield, X. O. (2000) HSV-1 amplicon vectors-simplicity and versatility. Mol. Ther. 2: 9-15.
102. Shinohara, H., Fukushi, M., Higuchi, M., Oie, M., Hoshi, O., Ushiki, T., Hayashi, J.-I. & Fujii, M. (2002) Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1. J. Virol. 76: 12917-12924.
103. Shire, K., Ceccarelli, D. F. J., Avolio-Hunter, T. M. & Frappier, L. (1999) EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J. Virol. 73,:2587-2595.
104. Shizuya, H., Birren, B., Kim, U. J., Mancino, V., Slepak, T., Tachiiri, Y. & Simon, M. (1992) Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. USA 89: 8794-7.
105. Simmer, B., Alt, M., Buckreus, I., Berthold, S., Fleckenstein, B., Platzer, E. & Grassmann, R. (1991) Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines, J. Gen. Virol. 72: 1953-1958.
106. Smith, P. G., Burchill, S. A., Brooke, D., Coletta, P. L. & Whitehouse, A. (2005a) Efficient infection and persistence of a herpesvirus saimiri-based gene delivery vector into human tumor xenografts and multicellular spheroid cultures. Cancer Gene Ther. 12: 248-56.
107. Smith, P. G., Coletta, P. L., Markham, A. F. & Whitehouse, A. (2001) In. vivo episomal maintenance of a herpesvirus saimiri-based gene delivery vector. Gene Ther. 8: 1762-9.
108. Smith, P. G., Oakley, F., Fernandez, M., Mann, D. A., Lemoine, N. R. & Whitehouse, A. (2005b) Herpesvirus saimiri-based vector biodistribution using noninvasive optical imaging. Gene Ther.., 12: 1465-1476.
109. Spaete, R. R. & Frenkel, N. (1982) The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 30: 295-304.
110. Stevenson, A. J., Clarke, D., Meredith, D. M., Kinsey, S. E., Whitehouse, A. & Bonifer, C. (2000a) Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in. vitro. Gene Ther. 7: 464-471.
111. Stevenson, A. J., Cooper, M., Griffiths, J. C., Gibson, P. C., Whitehouse, A., Jones, E. F., Markham, A. F., Kinsey, S. E. & Meredith, D. M. (1999) Assessment of herpesvirus saimiri as a potential human gene therapy vector. J. Med. Virol. 57: 269-77.
112. Stevenson, A. J., Frolova-Jones, E., Hall, K. T., Kinsey, S. E., Markham, A. F., Whitehouse, A. & Meredith, D. M. (2000b) A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy. Cancer Gene Ther. 7: 1077-85.
113. Stewart, J. P., Usherwood, E. J., Ross, A., Dyson, H. & Nash, T. (1998) Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187: 1941-51.
114. Szomolanyi, E., Medveczky, P. & Mulder, C. (1987) In vitro immortalization of marmoset cells with three subgroups of herpesvirus saimiri. J. Virol. 61: 3485-90.
115. Talbot, S. J., Weiss, R. A., Kellam, P. & Boshoff, C. (1999) Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257: 84-94.
116. Varghese, S. & Rabkin, S. D. (2002) Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther. 9: 967-78.
117. Verma, S. C. & Robertson, E. S. (2003) ORF73 of herpesvirus saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats. J. Virol. 77: 12494-12506.
118. Virgin, H., 4th, Latreille, P., Wamsley, P., Hallsworth, K., Weck, K., Dal Canto, A. & Speck, S. (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71: 5894-5904.
119. Wade-Martins, R., Saeki, Y. & Antonio Chiocca, E. (2003) Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementstion of low-density lipoprotein receptor deficiency in human cells. Mol. Ther. 7: 604-612.
120. Wade-Martins, R., Smith, E. R., Tyminski, E., Chiocca, E. A. & Saeki, Y. (2001) An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat. Biotechnol. 19: 1067-70.
121. Wade-Martins, R., White, R. E., Kimura, H., Cook, P. R. & James, M. R. (2000) Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene. Nat. Biotechnol. 18: 1311-4.
122. Weiskirchen, R., Kneifel, J., Weiskirchen, S., van de Leur, E., Kunz, D. & Gressner, A. M. (2000) Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts. BMC Cell Biol. 1: 4.
123. Wendtner, C. M., Kurzeder, C., Theiss, H. D., Kofler, D. M., Baumert, J., Delecluse, H. J., Janz, A., Hammerschmidt, W. & Hallek, M. (2003) High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors. Exp. Hematol. 31: 99-108.
124. Werner, F. J., Bomkamm, G. W., Fleckenstein, B. & Mulder, C. (1978) Episomal viral DNA in herpesvirus saimiri-transformed lymphoid cell lines. IARC scientific publications, 125-30.
125. White, R. E., Calderwood, M. A. & Whitehouse, A. (2003) Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. J. Gen. Virol. 84: 3393-403.
126. White, R. E., Wade-Martins, R. & James, M. R. (2002) Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector. Mol. Ther. 5: 427-35.
127. Wieser, C., Stumpf, D., Grillhosl, C., Lengenfelder, D., Gay, S., Fleckenstein, B. & Ensser, A. (2005) Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors. Gene Ther. 12: 395-406.
128. Wohlgemuth, J. G., Kang, S. H., Bulboaca, G. H., Nawotka, K. A. & Calos, M. P. (1996) Long-term gene expression from autonomously replicating vectors in mammalian cells. Gene Ther. 3: 503-12.
129. Wu, H., Kapoor, P. & Frappier, L. (2002) Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J. Virol. 76, 2480-2490.
130. Yates, J., Warren, N., Reisman, D. & Sugden, B. (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81: 3806-10.
131. Yates, J. L. & Guan, N. (1991) Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65: 483-8.
132. Yates, J. L., Warren, N. & Sugden, B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-5.
133. Ye, F. C., Zhou, F. C., Yoo, S. M., Xie, J. P., Browning, P. J. & Gao, S. J. (2004) Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J. Virol. 78: 11121-9.
134. Zhou, F. C., Zhang, Y. J., Deng, J. H., Wang, X. P., Pan, H. Y., Hettler, E. & Gao, S. J. (2002) Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 76: 6185-96.